PSA Levels, Kinetics May Predict PCa Bone Scan Results High PSA and short PSA double time are associated with a greater likelihood of a positive bone scan. PSA levels and kinetics may be used as ...
Background: Statin therapy has been associated with decreased serum PSA levels in men undergoing prostate cancer screening, lower rate of adverse pathologic features in radical prostatectomy specimens ...
Several studies have suggested that PSA kinetics might predict prostate cancer outcomes, although results have been conflicting. The increase in PSA over time (PSA VELOCITY; PSAV) is thought to ...
Effect of ID1 expression change following chemotherapy on chemotherapy sensitivity. Background: A number of phase II trials in men with noncastrate PSA-recurrent PC have assessed the impact of novel ...
“...a short time to PSA nadir ... is an independent predictor of poor survival...” Androgen deprivation therapy (ADT) is the most effective available treatment ...
Prostate-specific antigen (PSA) has been used for over two decades as a serum marker for adenocarcinoma of the prostate. Although PSA screening remains an important part of disease screening and ...
PSA density is routinely collected as part of prostate cancer active surveillance protocols, so monitoring kinetics confers no extra costs or burdens on patients, according to investigators. PSA ...
To the investigator and clinician, prostate-specific antigen (PSA) level is a seemingly perfect outcome measure because it is easily assessable, quantitative, reproducible, and inexpensive. Whether ...
Men with low-risk prostate cancer can usually safely forego treatment as long as they continue to monitor their disease with their clinicians, an expert said. While patients with prostate cancer do ...
Mari-Anne Rowlands, Kate Tilling, Jeff M. P. Holly, Chris Metcalfe, David Gunnell, Athene Lane, Michael Davis, Jenny Donovan, Freddie Hamdy, David E. Neal, Richard M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback